Vibration perception threshold as a measure of distal symmetrical peripheral neuropathy in type 1 diabetes: Results from the DCCT/EDIC study

Diabetes Care

Volumn 33, Issue 12, 2010, Pages 2635-2641

  Martin, Catherine L ^a   Waberski, Barbara H ^b   Pop Busui, Rodica ^a   Cleary, Patricia A ^b   Catton, Sarah ^c   Albers, James W ^a   Feldman, Eva L ^a   Herman, William H ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

^c UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CLINICAL ASSESSMENT; ELECTRODIAGNOSIS; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NERVE CONDUCTION DISORDER; PERCEPTIVE THRESHOLD; PERIPHERAL NEUROPATHY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; VIBRATION PERCEPTION THRESHOLD; VIBRATION SENSE;

ADOLESCENT; ADULT; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; MALE; PERCEPTION; PERIPHERAL NERVOUS SYSTEM DISEASES; PREDICTIVE VALUE OF TESTS; SENSORY THRESHOLDS; VIBRATION; YOUNG ADULT;

EID: 79951715424     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc10-0616     Document Type: Article

References (24)

1. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993;329:977-986
2. The effect of intensive diabetes therapy on the development and progression of neuropathy. The Diabetes Control and Complications Trial Research Group. Ann Intern Med 1995;122:561-568
3. Effect of intensive diabetes treatment on nerve conduction in the Diabetes Control and Complications Trial. Ann Neurol 1995;38:869-880
4. Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up for the Diabetes Control and Complications Trial cohort. Diabetes Care 1999;22:99-111
5. Feldman EL, Stevens MJ, Thomas PK, Brown MB, Canal N, Greene DA. A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care 1994;17:1281-1289 (Pubitemid 24324972)
6. Report and recommendations of the San Antonio Conference on Diabetic Neuropathy. Consensus statement. Diabetes 1988;37:1000-1004
7. Proceedings of a consensus development conference on standardized measures in diabetic neuropathy. Neurology 1992;42:1823-1839
8. Martin C, Waberski B, Pop-Busui R, Albers J, Herman W, Cleary P. Same day intra-subject reproducibility of vibration perception threshold in type 1 diabetes. Diabetologia 2008;51:S506
9. Arezzo J. Quantitative Sensory Testing of Vibration Threshold: Vibratron II. Clifton, NJ, Physitemp Instruments, 1993
10. Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas 1960;20:37-46
11. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993;39:561-577 (Pubitemid 23118304)
12. Boulton AJ, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R, Malik RA, Maser RE, Sosenko JM, Ziegler D, American Diabetes Association. Diabetic neuropathies: a statement from the American Diabetes Association. Diabetes Care 2005;28:956-962 (Pubitemid 40434506)
13. Malik RA, Tesfaye S, Newrick PG, Walker D, Rajbhandari SM, Siddique I, Sharma AK, Boulton AJ, King RH, Thomas PK, Ward JD. Sural nerve pathology in diabetic patients with minimal but progressive neuropathy. Diabetologia 2005;48:578-585 (Pubitemid 40487306)
14. Young MJ, Breddy JL, Veves A, Boulton AJ. The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds. A prospective study. Diabetes Care 1994;17:557-560 (Pubitemid 24161977)
15. Elliott J, Tesfaye S, Chaturvedi N, Gandhi RA, Stevens LK, Emery C, Fuller JH, EURODIAB Prospective Complications Study Group. Large-fiber dysfunction in diabetic peripheral neuropathy is predicted by cardiovascular risk factors. Diabetes Care 2009;32:1896-1900
16. Gelber DA, Pfeifer MA, Broadstone VL, Munster EW, Peterson M, Arezzo JC, Shamoon H, Zeidler A, Clements R, Greene DA. Components of variance for vibratory and thermal threshold testing in normal and diabetic subjects. J Diabetes Complicat 1995;9:170-176
17. Bril V, Kojic J, Ngo M, Clark K. Comparison of a neurothesiometer and vibration in measuring vibration perception thresholds and relationship to nerve conduction studies. Diabetes Care 1997;20:1360-1362 (Pubitemid 27366807)
18. Chong PS, Cros DP. Technology literature review: quantitative sensory testing. Muscle Nerve 2004;29:734-747 (Pubitemid 38620017)
19. Albers JW, Herman WH, Pop-Busui R, Feldman EL, Martin CL, Cleary PA, Waberski BH, Lachin JM, Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) study. Diabetes Care 2010;33:1090-1096
20. Albers JW, Herman WH, Pop-Busui R, Martin CL, Cleary P, Waberski B, Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Intervention and Complications (EDIC) Research Group. Subclinical neuropathy among Diabetes Control and Complications Trial participants without diagnosable neuropathy at trial completion: possible predictors of incident neuropathy? Diabetes Care 2007;30:2613-2618
21. Papanas N, Papatheodorou K, Papazoglou D, Monastiriotis C, Christakidis D, Maltezos E. A comparison of the new indicator test for sudomotor function (Neuropad) with the vibration perception threshold and the clinical examination in the diagnosis of peripheral neuropathy in subjects with type 2 diabetes. Exp Clin Endocrinol Diabetes 2008;116:135-138 (Pubitemid 351363386)
22. Davis EA, Jones TW, Walsh P, Byrne GC. The use of biothesiometry to detect neuropathy in children and adolescents with IDDM. Diabetes Care 1997;20:1448-1453 (Pubitemid 27366823)
23. Bril V, Perkins BA. Comparison of vibration perception thresholds obtained with the neurothesiometer and the CASE IV and relationship to nerve conduction studies. Diabet Med 2002;19:661-666 (Pubitemid 34985167)
24. Redmond JM, McKenna MJ, Feingold M, Ahmad BK. Sensory testing versus nerve conduction velocity in diabetic polyneuropathy. Muscle Nerve 1992;15:1334-1339